Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
07:56

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases

Published on: June 28, 2024

1.2K

Harnessing cervical lymphatic mechanics to enhance amyloid clearance: a paradigm shift in Alzheimer's therapeutics?

Wei Wang1, Junhui Lv2, Zihao Xu2

  • 1Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Translational Neurodegeneration
|November 5, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases
07:56

Author Spotlight: Developing Photo-Stimulation Technology for Toxin Removal in Sleep-Related Brain Diseases

Published on: June 28, 2024

1.2K
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782

Articles linked to this work by shared authors, journal, and citation graph.

Exercise Intervention for REM Sleep Behavior Disorder in Parkinson's Disease: Mechanisms and Implications for Neurorehabilitation.

CNS neuroscience & therapeutics·2026

Protein Disulfide Isomerase Disassembles TDP-43/G3BP1 Condensates and Antagonizes TDP-43 Pathological Aggregates.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

NAD+‒circadian rhythm coupling in dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder.

Signal transduction and targeted therapy·2026

Sleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms.

Neuroscience bulletin·2026

The clinical features, imaging profiles, and management strategies of cerebellar infarction: an update.

International journal of surgery (London, England)·2026

Capsaicin suppresses microglial inflammation through TRPV1-SSR4 interaction.

Translational neurodegeneration·2026

Exercise promotes lipophagy and mitigates cognitive impairment in Alzheimer's disease through downregulating microglial TMEM9.

Translational neurodegeneration·2026

Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons.

Translational neurodegeneration·2026

The glymphatic-lymphatic axis: known pathways, open questions, and emerging roles in neurodegeneration.

Translational neurodegeneration·2026

Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases.

Translational neurodegeneration·2026

Microglia-derived extracellular vesicle content as a biomarker for early detection of Alzheimer's disease.

Translational neurodegeneration·2026

A Collapse-Resistant Red-Billed Blue Magpie Optimizer for Employment-Policy Design: Programme Targeting and Occupational Retraining Pathways.

Biomimetics (Basel, Switzerland)·2026

Development and Characterization of Phlomis brachyodon Extract-Loaded Thermoresponsive In Situ Gels: Antioxidant Activity, Wound-Healing Evaluation in a Rat Excision Model, and Potential Anticancer Activity.

Gels (Basel, Switzerland)·2026

Arbutin/kojic acid-loaded MHA hydrogel array patches attenuate UVB-induced epidermal hyperplasia and remodeling-associated responses.

Journal of applied biomaterials & functional materials·2026

BMI1 Overexpression Alleviates Metabolic Syndrome-Related Liver Injury by Inhibiting the Activation of the METTL3/AHNAK Axis.

The Kaohsiung journal of medical sciences·2026

Restoring Endothelial Mitochondrial Homeostasis With a Bioactive Nanoshield Promotes Vascular Regeneration on Cardiovascular Implants.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

HBV-Associated Immune Remodeling of TNFSF10+ Monocytes Through the LPAR3-GALNT4 Axis During Pregnancy.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us